224 related articles for article (PubMed ID: 31770443)
1. Clonal dynamics in chronic lymphocytic leukemia.
Gutierrez C; Wu CJ
Blood Adv; 2019 Nov; 3(22):3759-3769. PubMed ID: 31770443
[TBL] [Abstract][Full Text] [Related]
2. Clonal dynamics in chronic lymphocytic leukemia.
Gutierrez C; Wu CJ
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):466-475. PubMed ID: 31808879
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
Sutton LA; Rosenquist R
Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
[TBL] [Abstract][Full Text] [Related]
4. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
Sutton LA; Rosenquist R
Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts.
Davies NJ; Kwok M; Gould C; Oldreive CE; Mao J; Parry H; Smith E; Agathanggelou A; Pratt G; Taylor AMR; Moss P; Griffiths M; Stankovic T
Oncotarget; 2017 Jul; 8(27):44749-44760. PubMed ID: 28496009
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
7. Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy.
Mato AR; Wierda WG; Davids MS; Cheson BD; Coutre SE; Choi M; Furman RR; Heffner L; Barr PM; Eradat H; Ford SM; Zhou L; Verdugo M; Humerickhouse RA; Potluri J; Byrd JC
Haematologica; 2019 Nov; 104(11):2258-2264. PubMed ID: 30923097
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic lymphocytic leukemia.
Ghia P; Hallek M
Haematologica; 2014 Jun; 99(6):965-72. PubMed ID: 24881042
[TBL] [Abstract][Full Text] [Related]
9. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
Schuh A; Becq J; Humphray S; Alexa A; Burns A; Clifford R; Feller SM; Grocock R; Henderson S; Khrebtukova I; Kingsbury Z; Luo S; McBride D; Murray L; Menju T; Timbs A; Ross M; Taylor J; Bentley D
Blood; 2012 Nov; 120(20):4191-6. PubMed ID: 22915640
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia treatment algorithm 2018.
Parikh SA
Blood Cancer J; 2018 Oct; 8(10):93. PubMed ID: 30283014
[TBL] [Abstract][Full Text] [Related]
11. Key Molecular Drivers of Chronic Lymphocytic Leukemia.
Alsagaby SA; Brennan P; Pepper C
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):593-606. PubMed ID: 27601002
[TBL] [Abstract][Full Text] [Related]
12. Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Mato AR; Thompson M; Allan JN; Brander DM; Pagel JM; Ujjani CS; Hill BT; Lamanna N; Lansigan F; Jacobs R; Shadman M; Skarbnik AP; Pu JJ; Barr PM; Sehgal AR; Cheson BD; Zent CS; Tuncer HH; Schuster SJ; Pickens PV; Shah NN; Goy A; Winter AM; Garcia C; Kennard K; Isaac K; Dorsey C; Gashonia LM; Singavi AK; Roeker LE; Zelenetz A; Williams A; Howlett C; Weissbrot H; Ali N; Khajavian S; Sitlinger A; Tranchito E; Rhodes J; Felsenfeld J; Bailey N; Patel B; Burns TF; Yacur M; Malhotra M; Svoboda J; Furman RR; Nabhan C
Haematologica; 2018 Sep; 103(9):1511-1517. PubMed ID: 29880613
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
Takizawa J
Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
[TBL] [Abstract][Full Text] [Related]
14. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
Del Giudice I; Marinelli M; Wang J; Bonina S; Messina M; Chiaretti S; Ilari C; Cafforio L; Raponi S; Mauro FR; Di Maio V; De Propris MS; Nanni M; Ciardullo C; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
Br J Haematol; 2016 Feb; 172(3):371-383. PubMed ID: 26597680
[TBL] [Abstract][Full Text] [Related]
15. The clonal evolution of Richter transformation cells uncovers therapeutic vulnerabilities.
Nat Med; 2022 Aug; 28(8):1546-1547. PubMed ID: 35953722
[No Abstract] [Full Text] [Related]
16. Gene mutations in chronic lymphocytic leukemia.
Amin NA; Malek SN
Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
Rossi D; Gerber B; Stüssi G
Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
[TBL] [Abstract][Full Text] [Related]
18. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
19. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract][Full Text] [Related]
20. SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia.
Condoluci A; Rossi D
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):779-784. PubMed ID: 33039357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
